Hartline Investment Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,099
| Closed | -$1.04M | – | 142 |
|
|
2024
Q1 | $1.04M | Buy |
19,099
+15,181
| +387% | +$823K | 0.18% | 123 |
|
|
2023
Q4 | $201K | Hold |
3,918
| – | – | 0.03% | 104 |
|
|
2023
Q3 | $227K | Hold |
3,918
| – | – | 0.04% | 99 |
|
|
2023
Q2 | $251K | Sell |
3,918
-320
| -8% | -$20.5K | 0.04% | 97 |
|
|
2023
Q1 | $294K | Hold |
4,238
| – | – | 0.06% | 93 |
|
|
2022
Q4 | $305K | Buy |
+4,238
| New | +$305K | 0.07% | 92 |
|
|
2022
Q3 | – | Sell |
-26,623
| Closed | -$1.65M | – | 160 |
|
|
2022
Q2 | $1.65M | Buy |
26,623
+13,457
| +102% | +$835K | 0.24% | 56 |
|
|
2022
Q1 | $880K | Buy |
13,166
+3,518
| +36% | +$235K | 0.11% | 79 |
|
|
2021
Q4 | $602K | Sell |
9,648
-3,255
| -25% | -$203K | 0.08% | 80 |
|
|
2021
Q3 | $763K | Sell |
12,903
-263
| -2% | -$15.6K | 0.11% | 83 |
|
|
2021
Q2 | $880K | Sell |
13,166
-2,167
| -14% | -$145K | 0.11% | 79 |
|
|
2021
Q1 | $968K | Sell |
15,333
-11,290
| -42% | -$713K | 0.15% | 73 |
|
|
2020
Q4 | $1.65M | Sell |
26,623
-7,817
| -23% | -$485K | 0.24% | 56 |
|
|
2020
Q3 | $2.08M | Sell |
34,440
-32,937
| -49% | -$1.99M | 0.35% | 45 |
|
|
2020
Q2 | $3.96M | Sell |
67,377
-9,299
| -12% | -$547K | 0.83% | 29 |
|
|
2020
Q1 | $4.27M | Sell |
76,676
-1,565
| -2% | -$87.2K | 1.07% | 23 |
|
|
2019
Q4 | $5.02M | Buy |
+78,241
| New | +$5.02M | 1.08% | 24 |
|